-
The efficacy of statins in preventing cardiovascular events is well known, but approximately 10% of patients will develop elevations in liver function tests (LFTs).
-
This paper analyzes data from the national icd registry, which tracks ICD implantations for the primary prevention of sudden death in the United States.
-
The relationship between blood pressure and cardiovascular events remains controversial, especially in patients with coronary artery disease who may need increased pressures to have adequate myocardial perfusion.
-
Post-pericardiotomy syndrome (PPS) is relatively common after cardiac surgery, and can result in life-threatening events, such as cardiac tamponade, increased length of stay, readmission to hospital, and significant patient discomfort.
-
New high-sensitivity cardiac troponin assays detect blood levels in many patients with chronic heart failure or ischemic heart disease who do not meet clinical criteria for myocardial infarction.
-
Gastrointestinal (GI) bleeding is a major complication of dual anti-platelet therapy (DAPT) with aspirin and clopidogrel.
-
Over the last twenty years, the proportion of cardiac-arrest victims in whom pulseless electric activity (PEA) is identified rather than asystole or ventricular fibrillation as the initial ECG finding has been increasing.
-
-
Rivaroxaban may be dabigatran's first competitor; a new way to measure non-adherence to medication therapy; FDA Actions.
-
Progressive, compensatory left ventricular hypertrophy (LVH) in aortic stenosis (AS) ultimately leads to myocardial injury, fibrosis, and LV dysfunction.
